Company / Cash per Share
Intellia Therapeutics, Inc. Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$1.52
FY2025
5-year range
$1.52 / $2.60
FY2021-FY2025
Trend
-25.1%
vs FY2024
Sector context
#96 of 146
Health Care
What the data says
At $1.52, Intellia Therapeutics, Inc.'s cash per share ranks #96 of 146 in the Health Care sector. Cash per Share has fluctuated over the past 10 years, ranging from $1.30 in FY2019 to $12.29 in FY2016.
Based on SEC 10-K filings.
1.52 in FY2025 with a 5-year CAGR of -13.7%.
Declined from $2.60 to $1.52 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -2.8%
- 5-Year CAGR
- -13.7%
- 10-Year CAGR
- -
Sector benchmark
#96 of 146 in Health CareTop 66% of 146This company $1.52 Sector average $27.70
▼
-94.5% below sector average
Key checks
Key Insights
- In FY2025, cash per share decreased 25.1% year-over-year.
- Ranks #96 out of 146 companies in the Health Care sector.
- Peak cash per share was recorded in FY2016.
- Lowest cash per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.14 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.52 | -25.1% |
| FY2024 | $2.03 | -21.9% |
| FY2023 | $2.60 | +57.1% |
| FY2022 | $1.66 | -31.4% |
| FY2021 | $2.42 | -24.2% |
| FY2020 | $3.19 | +144.9% |
| FY2019 | $1.30 | -83.8% |
| FY2018 | $8.04 | -15.0% |
| FY2017 | $9.46 | -23.0% |
| FY2016 | $12.29 | -96.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026